California Selects Civica Rx as Its Insulin Manufacturing Partner
LEHI, Utah--(BUSINESS WIRE)--Civica Inc. (Civica, Civica Rx) today announced it will manufacture insulins for the State of California's CalRx Biosi...
March 18, 2023
8:08 PM
LEHI, Utah--(BUSINESS WIRE)--Civica Inc. (Civica, Civica Rx) today announced it will manufacture insulins for the State of California's CalRx Biosimilar Insulin Initiative as part of its insulin manufacturing work. Once approved, Civica's biosimilar versions of the most commonly used short-and long-acting insulins will be available to Californians and nationwide at significantly lower prices than insulins currently on the market. The availability of these insulins will benefit Californians with